ImmunityBio, Inc. (IBRX) — research page
US · us-cm-kg/NASDAQ/IBRX · as of 2026-11-08
Identity and listing
The issuer is ImmunityBio, Inc., listed on NASDAQ under ticker IBRX, with ISIN US45256X1037 and LEI 529900J9XLBR4HFL4B83. Its security type is Corporate and its sector is 2836 Biological Products, (No Diagnostic Substances). Its jurisdiction is United States, Delaware, and its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | ImmunityBio, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | IBRX | source · 2026-11-08 |
| ISIN | US45256X1037 | source · 2026-11-08 |
| LEI | 529900J9XLBR4HFL4B83 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 69 filings across 41 filing days in the window 2025-11-08 to 2026-11-08. By type, the record holds 31 directors' dealings, 15 regulatory filings, 10 corporate news, 8 results, 3 AGM/EGM, 1 director change and 1 prospectus. The median gap between filing days is 4.0 days. The latest filing is dated 2026-10-14 and is of type corporate_news, and 25 days separate it from the record date. The exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days across 4,359 issuers. The sector median is 65.5 filings, a cadence gap of 5.5 days and a latency of 4.0 days across 176 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 69 | 4 | 25 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-14 | corporate_news | 8-K | 8-K — 8-K (items 7.01,9.01) |
| 2026-10-06 | directors_dealings | 4 | 4 — FORM 4 |
| 2026-10-06 | directors_dealings | 4 | 4 — FORM 4 |
| 2026-10-05 | regulatory_filing | 144 | 144 |
| 2026-10-02 | regulatory_filing | 144 | 144 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record. The latest annual report cover carries no dei:AuditorName tag, and the location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001326110.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/IBRX (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/IBRX (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US45256X1037"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f8e4dc3fb9fb746f.